First Time Loading...
S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 91 200 KRW -1.51% Market Closed
Updated: May 11, 2024

Intrinsic Value

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. [ Read More ]

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 129 191.06 KRW. Compared to the current market price of 91 200 KRW, ST Pharm Co Ltd is Undervalued by 29%.

Key Points:
Intrinsic Value
Base Case
129 191.06 KRW
Undervaluation 29%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
ST Pharm Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ST Pharm Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
ST Pharm Co Ltd

Provide an overview of the primary business activities
of ST Pharm Co Ltd.

What unique competitive advantages
does ST Pharm Co Ltd hold over its rivals?

What risks and challenges
does ST Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ST Pharm Co Ltd.

Provide P/S
for ST Pharm Co Ltd.

Provide P/E
for ST Pharm Co Ltd.

Provide P/OCF
for ST Pharm Co Ltd.

Provide P/FCFE
for ST Pharm Co Ltd.

Provide P/B
for ST Pharm Co Ltd.

Provide EV/S
for ST Pharm Co Ltd.

Provide EV/GP
for ST Pharm Co Ltd.

Provide EV/EBITDA
for ST Pharm Co Ltd.

Provide EV/EBIT
for ST Pharm Co Ltd.

Provide EV/OCF
for ST Pharm Co Ltd.

Provide EV/FCFF
for ST Pharm Co Ltd.

Provide EV/IC
for ST Pharm Co Ltd.

Show me price targets
for ST Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for ST Pharm Co Ltd?

How accurate were the past Revenue estimates
for ST Pharm Co Ltd?

What are the Net Income projections
for ST Pharm Co Ltd?

How accurate were the past Net Income estimates
for ST Pharm Co Ltd?

What are the EPS projections
for ST Pharm Co Ltd?

How accurate were the past EPS estimates
for ST Pharm Co Ltd?

What are the EBIT projections
for ST Pharm Co Ltd?

How accurate were the past EBIT estimates
for ST Pharm Co Ltd?

Compare the revenue forecasts
for ST Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ST Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ST Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of ST Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of ST Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing ST Pharm Co Ltd with its peers.

Analyze the financial leverage
of ST Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for ST Pharm Co Ltd.

Provide ROE
for ST Pharm Co Ltd.

Provide ROA
for ST Pharm Co Ltd.

Provide ROIC
for ST Pharm Co Ltd.

Provide ROCE
for ST Pharm Co Ltd.

Provide Gross Margin
for ST Pharm Co Ltd.

Provide Operating Margin
for ST Pharm Co Ltd.

Provide Net Margin
for ST Pharm Co Ltd.

Provide FCF Margin
for ST Pharm Co Ltd.

Show all solvency ratios
for ST Pharm Co Ltd.

Provide D/E Ratio
for ST Pharm Co Ltd.

Provide D/A Ratio
for ST Pharm Co Ltd.

Provide Interest Coverage Ratio
for ST Pharm Co Ltd.

Provide Altman Z-Score Ratio
for ST Pharm Co Ltd.

Provide Quick Ratio
for ST Pharm Co Ltd.

Provide Current Ratio
for ST Pharm Co Ltd.

Provide Cash Ratio
for ST Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for ST Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for ST Pharm Co Ltd?

What is the current Free Cash Flow
of ST Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for ST Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ST Pharm Co Ltd

Current Assets 348.4B
Cash & Short-Term Investments 90.1B
Receivables 122.6B
Other Current Assets 135.7B
Non-Current Assets 327.1B
Long-Term Investments 17.7B
PP&E 280.1B
Intangibles 13.5B
Other Non-Current Assets 15.7B
Current Liabilities 83.7B
Accounts Payable 17.7B
Accrued Liabilities 8.3B
Short-Term Debt 20.9B
Other Current Liabilities 36.9B
Non-Current Liabilities 207.1B
Long-Term Debt 161.8B
Other Non-Current Liabilities 45.3B
Efficiency

Earnings Waterfall
ST Pharm Co Ltd

Revenue
285B KRW
Cost of Revenue
-172.9B KRW
Gross Profit
112.1B KRW
Operating Expenses
-78.6B KRW
Operating Income
33.5B KRW
Other Expenses
-13.9B KRW
Net Income
19.6B KRW

Free Cash Flow Analysis
ST Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

ST Pharm Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
47/100
Profitability
Score

ST Pharm Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ST Pharm Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
High Altman Z-Score
Low D/E
81/100
Solvency
Score

ST Pharm Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 110 415 KRW with a low forecast of 96 960 KRW and a high forecast of 147 000 KRW.

Lowest
Price Target
96 960 KRW
6% Upside
Average
Price Target
110 415 KRW
21% Upside
Highest
Price Target
147 000 KRW
61% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
ST Pharm Co Ltd

1M 1M
+14%
6M 6M
+30%
1Y 1Y
+7%
3Y 3Y
-26%
5Y 5Y
+352%
10Y 10Y
+99%
Annual Price Range
91 200
52w Low
60 400
52w High
99 800
Price Metrics
Average Annual Return 73.03%
Standard Deviation of Annual Returns 123.7%
Max Drawdown -58%
Shares Statistics
Market Capitalization 1.7T KRW
Shares Outstanding 18 933 900
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ST Pharm Co Ltd

Country

Korea

Industry

Life Sciences Tools & Services

Market Cap

1.7T KRW

Dividend Yield

0%

Description

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Contact

GYEONGGI-DO
Siheung
802, Sihwa Industrial Complex 1 Na, 231, Hyeomnyeok-ro
+82314993002
http://www.stpharm.co.kr/

IPO

2016-06-23

Employees

-

Officers

CEO & Director
Mr. Geun-Jo Im Ph.D.
Sr. MD & GM of Oligo Research Department
Dr. Kyeong Eun Jung Ph.D.
Head of Management Support Division & Inside Director
Mr. Dong-Ryul Lee
MD & Chief of Quality Assurance Office
Mr. Jung-Young Seok
MD & Banwol 1st Factory Mang.
Mr. Soon-Gi Jang
MD & GM of Sales 1st Department
Mr. Seok-Woo Choi
Show More
Research Director & Inside Director
Dr. Kyeong-Jin Kim
Show Less

See Also

Discover More
What is the Intrinsic Value of one ST Pharm Co Ltd stock?

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 129 191.06 KRW.

Is ST Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 91 200 KRW, ST Pharm Co Ltd is Undervalued by 29%.